Advertisement
Research Topics
Subscribe to Research Topics
View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Roche, Qualcomm to Collaborate on Remote Patient Monitoring

January 29, 2015 9:04 am | News | Comments

This is a strategic collaboration to improve remote monitoring and management of chronic disease patients. Read more...                        

New Method for Identifying Aggressive Childhood Cancers

January 29, 2015 8:58 am | by Lund University | News | Comments

When a cancerous cell divides, the chromosomes often end up in the wrong place, or break and combine in incorrect ways. Read more....                     

WHO: Ebola Response Shifts to Ending Epidemic

January 29, 2015 8:47 am | by Maria Cheng - AP Medical Writer | News | Comments

Health officials are now focused on ending the biggest-ever Ebola outbreak rather than just slowing the deadly virus' spread, the World Health Organization said Thursday. Read more...             

Advertisement

Dr. Oz and the Weight Loss Claim Controversy

January 28, 2015 5:14 pm | by Ryan Bushey, Associate Editor | Articles | Comments

A guest that has appeared on The Doctor Oz show was at the center of a lawsuit filed by the FTC. Read more...                        

U.S. Measles Outbreak Hits 87 Cases and Counting

January 28, 2015 12:33 pm | by Stephanie Guzowski, Editor | Articles | Comments

The measles outbreak, which originated at Disneyland, continues to expand, with 87 confirmed cases in people ranging in ages from 7 months to 70 years. Read more...                                     

Possible Therapeutic Target for Brain Blood Vessel Disorder

January 28, 2015 11:56 am | by University of Pennsylvania | News | Comments

Tens of millions of people around the world have abnormal, leak-prone sproutings of blood vessels in the brain called cerebral cavernous malformations (CCMs). These abnormal growths can lead to seizures, strokes, hemorrhages, and other serious conditions, yet their precise molecular cause has never been determined. Read more...

Drug Combo Suppresses Late-Stage Prostate Cancer Growth

January 28, 2015 11:37 am | by Purdue University | News | Comments

Low doses of metformin, a widely used diabetes medication, and a gene inhibitor known as BI2536 can successfully halt the growth of late-stage prostate cancer tumors, a Purdue University study finds. Read more...                          

IntelliCell BioSciences Licenses Indication for Diabetes to Invigorcell

January 28, 2015 11:32 am | by IntelliCell BioSciences | News | Comments

IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company"), a regenerative medicine company utilizing adult autologous stromal vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced a license agreement for the indication of Diabetes Mellitus. Read more...

Advertisement

Diet and Nutrition Essential for Mental Health

January 28, 2015 9:18 am | by University of Melbourne | News | Comments

Evidence is rapidly growing showing vital relationships between both diet quality and potential nutritional deficiencies and mental health. Read more....                  

Scientists Find Potential Anti-Cancer Use for Anti-Epilepsy Drug

January 28, 2015 9:11 am | by University of York | News | Comments

Scientists studied phenytoin, a drug which inhibits epilepsy by targeting sodium channels. Read more...                          

Amgen Submits Application in U.S. and Europe for Multiple Myeloma Treatment

January 28, 2015 9:05 am | News | Comments

The drug is an injection that can treat patients with relapsed multiple myeloma who have received at least one prior therapy. Read more...                     

Malvern's New Platform Enhances Analysis of Macromolecules

January 28, 2015 8:57 am | News | Comments

The platform breaks new ground in delivering the high performance, ease of use and productivity demanded in today’s analytical laboratories. Read more...            c       

Liberia: Only 5 People Being Treated for Ebola in Country

January 28, 2015 8:53 am | by Jonathan Paye-Layleh - Associated Press | News | Comments

Liberia said Monday that there are currently only five confirmed cases of Ebola in the entire country - a dramatic turnaround in the West African nation where the virus has taken its deadliest toll. Read more...        

Advertisement

Mylan Expands Hepatitis C Licensing Agreement with Gilead

January 26, 2015 11:18 am | by Associated Press | News | Comments

 Mylan Inc. announced that its subsidiary Mylan Laboratories Limited is expanding its hepatitis C licensing agreement with Gilead Sciences, Inc. to include the non-exclusive rights to manufacture and distribute the investigational NS5A inhibitor GS-5816 and single tablet regimen of sofosbuvir(Sovaldi)/GS-5816, once approved, in 91 developing countries. Read more...

New Model for Combatting the Ebola Epidemic

January 26, 2015 11:15 am | by Columbia University | News | Comments

An ICAP team conducted a three-week rapid assessment of Ebola community care centers. Read more...                           

UK Nurse Who Contracted Ebola Recovers, Leaves Hospital

January 26, 2015 11:08 am | by Associated Press | News | Comments

A British nurse who contracted Ebola while working in Sierra Leone has been discharged from the hospital after making a complete recovery. Read more...                               

Neural Spines Operate Like Miniature Neurons

January 26, 2015 11:04 am | by LMU | News | Comments

A recent study by teams of neurobiologists based at LMU and Regensburg addresses the role of the short protrusions called “spines” that form on the dendrites of nerve cells in the mammalian olfactory bulb. Dendrites serve as receptors for signals delivered by the so-called axons of other neurons. Read more...

Shire's Hunter Syndrome Treatment Gains FDA Fast Track Designation

January 26, 2015 10:59 am | News | Comments

Shire's drug treats the neurocognitive decline associated with Hunter syndrome. Read more...                           

Study Finds Potential New Drug Target for Lung Cancer

January 26, 2015 10:46 am | by Kentucky University | News | Comments

A new study by University of Kentucky Markey Cancer Center researchers suggests that targeting a key enzyme and its associated metabolic programming may lead to novel drug development to treat lung cancer. Read more...              

How Cancer Turns Good Cells to the Dark Side

January 26, 2015 10:39 am | by Rice University | News | Comments

Cancer uses a little-understood element of cell signaling to hijack the communication process and spread, according to Rice University researchers. Read more...                             

Tide Turning in Ebola Fight After Hard Lessons

January 26, 2015 10:34 am | by Associated Press | News | Comments

A top U.N. official in the fight against Ebola greeted just three patients at one treatment center he visited this week in Sierra Leone. Families in Liberia are no longer required to cremate the remains of loved ones to halt the spread of the virulent disease. Read more...

WHO Adopts Reforms to Repair Reputation After Ebola

January 26, 2015 10:07 am | News | Comments

The World Health Organization has proposed reforms that could overhaul its structure after botching the response to the biggest-ever Ebola outbreak, a sluggish performance that experts say cost thousands of lives. Read more...                                    

Added Protections for Consumer Info on Health Website

January 26, 2015 9:56 am | by Associated Press | News | Comments

The Obama administration appears to be making broader changes to protect consumer information on the government's health insurance website, after objections from lawmakers and privacy advocates. Read more...                 

Medical Pot Only OK for Sick Kids Failed by Other Drugs: MDS

January 26, 2015 9:52 am | by Lindsey Tanner, AP Medical Writer - Associated Press | News | Comments

With virtually no hard proof that medical marijuana benefits sick children, and evidence that it may harm developing brains, the drug should only be used for severely ill kids who have no other treatment option, the nation's most influential pediatricians group says in a new policy. Read more...

Meningococcal Vaccine Gets FDA Approval

January 26, 2015 9:44 am | by FDA | News | Comments

The U.S. Food and Drug Administration today approved Bexsero, a vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. Read more..                       

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading